Tiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest Update

Tiziana Life Sciences Ltd (NASDAQ:TLSA) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 60,600 shares, a growth of 44.6% from the September 15th total of 41,900 shares. Based on an average daily volume of 252,300 shares, the days-to-cover ratio is currently 0.2 days.

Tiziana Life Sciences Trading Down 1.2 %

Shares of NASDAQ:TLSA traded down $0.01 on Monday, reaching $0.93. The company had a trading volume of 25,556 shares, compared to its average volume of 193,362. Tiziana Life Sciences has a 52-week low of $0.41 and a 52-week high of $1.74. The firm’s 50 day simple moving average is $1.05 and its 200-day simple moving average is $0.87.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.